Table of ContentsView AllTable of ContentsSymptoms of Blood CancerLeukemiaLymphomaMultiple MyelomaMyelodysplastic Syndrome (MDS)Myeloproliferative Disorder (MPD)
Table of ContentsView All
View All
Table of Contents
Symptoms of Blood Cancer
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndrome (MDS)
Myeloproliferative Disorder (MPD)
Blood cancers, also called hematologic cancers, occur when blood cells grow abnormally, interfering with how normal blood cells function. Types of blood cancer vary based on the cells they affect as well as their incidence, method of diagnosis, and their prognosis. There are three main types of blood cancer:
Less common types of blood cancer include myelodysplastic syndrome (MDS) and myeloproliferative disorder (MPD).
This article covers the common symptoms of blood cancer. It also looks at the different types and risk factors.
KATERYNA KON / SCIENCE PHOTO LIBRARY / Getty Images
Symptoms of blood cancer can vary depending on the type, but common symptoms include:
The causes of blood cancer are not fully understood. Experts believe that blood cancer may develop from inherited genetic mutations, smoking, and environmental factors like exposure to chemicals and radiation.
Leukemiais the most common cancer for people who are more than 55 years old and children who are younger than 15 years old. It occurs in the bone marrow when abnormal white blood cells are created too quickly and destroy normal blood cells.
Types
Acute leukemia occurs quickly and can become severe in only a short time, while chronic leukemia is slow-growing and will advance slowly.
There are four common types of leukemia. Types are determined based on how quickly the disease progresses, and which white blood cells are impacted.
AML
Acute myeloid leukemia (AML)is the most common form of leukemia in adults. It is fast-growing and impacts the blood and bone marrow. Treatment options include chemotherapy, radiation therapy, targeted therapy, or stem cell transplants.
ALL
Acute lymphocytic (lymphoblastic) leukemia (ALL)progresses rapidly and can affect the blood marrow throughout the body. It can spread to the liver, spleen, or lymph nodes. It is most common in children under 15 years old or adults over 45 years old. ALL accounts for the largest diagnosis of leukemia in children under 15 years old, but it is rare in adults.
CLL
Chronic lymphocytic leukemia (CLL)usually impacts older adults and accounts for a third of all leukemia diagnoses; its incidence being very close to that of AML. Some forms of CLL begin slowly and symptoms may not be obvious for years, while other forms of CLL grow quickly.
HCL
Hairy cell leukemia (HCL)is a rare form of CLL. It progresses slowly and most commonly occurs in middle-aged people or older people. HCL is a chronic disease.
CML
Just 10% of leukemias are chronic myeloid leukemia (CML). It is more common in adults than in children and can change from a slow progression to rapid growth.Unlike other forms of leukemia, CML has been associated with an abnormal chromosome known as the Philadelphia chromosome (Ph chromosome). Eventually it can spread to other parts of the body.
Risk factors
Risk factors for leukemia include:
Prognosis
Although there is no cure for leukemia, survival rates for leukemia have improved in recent years. Between 2010 and 2016 the five-year survival rate was 63.7%.
Lymphomais the result of abnormal white cells called lymphocytes multiplying rapidly and overwhelming the lymphatic system.
What’s the Difference Between Hodgkin Lymphoma and Non-Hodgkin Lymphoma ?The main diagnostic difference between Hodgkin lymphoma and non-Hodgkin lymphoma is seen in a biopsy. If Reed-Sternberg cells are present, then the patient has Hodgkin lymphoma.
What’s the Difference Between Hodgkin Lymphoma and Non-Hodgkin Lymphoma ?
The main diagnostic difference between Hodgkin lymphoma and non-Hodgkin lymphoma is seen in a biopsy. If Reed-Sternberg cells are present, then the patient has Hodgkin lymphoma.
There are two main forms of lymphoma:
Risk Factors
Those aged between 15 to 35 or over 55 are at increased risk for Hodgkin lymphoma, while those aged over 60 are at risk for non-Hodgkin lymphoma.
Those with a weakened immune system are at risk for lymphoma, as are those who have had viruses like HIV or Epstein-Barr.
The five-year survival rate for Hodgkin lymphoma is 89%.The five-year survival rate for diffuse large B cell lymphoma(DLBCL) is 65% and for follicular lymphoma is 90%. DLBCL and follicular lymphoma are the most common types of non-Hodgkin lymphoma.
Monoclonal gammopathy of undetermined significance (MGUS)is a benign condition that puts patients at an increased risk for cancer. On average, every year, 1% of people with MGUS go on to develop multiple myeloma.
Smoldering myeloma is a precancerous condition where half of those diagnosed will progress to multiple myeloma within five years.
Men are more more likely to be diagnosed with multiple myeloma than women. African-Americans are twice as likely to be diagnosed with multiple myeloma than Caucasians.
Although multiple myeloma is treatable, it is rarely curable. The five-year survival rate for myeloma is 52%.
Inmyelodysplastic syndrome (MDS), abnormal blood cells in the bone marrow struggle to make new blood cells. This can impact different types of cells, but most commonly results in a shortage of red blood cells. There are different kinds of MDS that are categorized based on blood cells affected. In one in three patients, MDS can progress to acute myeloid leukemia (AML). In the past, the condition has been referred to as preleukemia.
There are three different types of MDS:
Risk factors include:
A stem cell transplant is the only potential cure for MDS. Survival rates vary based on type of MDS, progression to AML, and other risk factors. The average survival rate for lower-risk patients who do not receive a bone marrow transplant is five years, while the five-year survival for high-risk patients is five months.
Myeloproliferative disorder (MPD), also referred to asmyeloproliferative neoplasm, causes the abnormal growth of blood cells in the bone marrow. It can affect platelets, white blood cells, and red blood cells.
Types of MPD include:
Risk factors vary based on type of MPD. Age, gender, and exposure to high levels of radiation, chemicals, or wiring may increase risk.
Survival rates are highly variable and depend on type of MPD, overall health, and response to treatment. Prognosis is generally good with appropriate treatment. The leukemic transformation in MPD differs with the type of MPD. The risk at 10 years may be as high as 20% in myelofibrosis.
A Word From Verywell
Survival rates from blood cancer have improved in recent years, thanks to newer treatments. As there are not currently any effective screening options for early detection of blood cancer, if you experience any unusual symptoms like fever and chills, coughing, chest pain, loss of appetite, night sweats, or other unusual symptoms, speak with your healthcare provider, especially if you have any risk factors.
24 Sources
Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read oureditorial processto learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
UMPC Hillman Cancer Center.Blood cancer symptoms and diagnosis.
Yale Medicine.Blood cancers.
UPMC Hillman Cancer Center.Leukemia.
Cancer Treatment Centers Of America.Types of leukemia.
Cancer Treatment Centers of America.Acute myeloid leukemia.
Cancer Treatment Centers of America.Acute lymphocytic leukemia.
Cancer Treatment Centers of America.Hairy cell leukemia.
Cancer Treatment Centers of America.Chronic myeloid leukemia.
Memorial Sloan Kettering Cancer Center.Risk factors for leukemia.
National Cancer Institute.Cancer stat facts: leukemia.
UPMC Hillman Cancer Center.Lymphoma.
Cancer Treatment Centers of America.What’s the difference? Hodgkin lymphoma and non-Hodgkin lymphoma
American Cancer Society.Survival rates for Hodgkin lymphoma.
American Cancer Society.Survival rates and factors that affect prognosis (outlook) for non-Hodgkin lymphoma.
Cancer Treatment Centers of America.Multiple myeloma.
National Cancer Institute.MGUS to myeloma: Study suggests risk of progression can change.
National Cancer Institute.Drug shows promise in slowing progression of smoldering myeloma to cancer.
UPMC Hillman Cancer Center.Multiple myeloma.
American Cancer Society.What are myelodysplastic syndromes?
UPMC Hillman Cancer Center.MDS.
MDS Foundation.What is MDS?
UPMC Hillman Cancer Center.Myeloproliferative disorder (MPD)
UPMC Hillman Cancer Center.Myeloproliferative disorder (MPD).
Meet Our Medical Expert Board
Share Feedback
Was this page helpful?Thanks for your feedback!What is your feedback?OtherHelpfulReport an ErrorSubmit
Was this page helpful?
Thanks for your feedback!
What is your feedback?OtherHelpfulReport an ErrorSubmit
What is your feedback?
